ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ZVSA ZyVersa Therapeutics Inc

0.7982
-0.0028 (-0.35%)
14 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -985k-4.59M-17.05M-2.9M-1.78M-2.83M-2.75M-2.27M
Pre Tax Income -631k-4.59M-86.33M-2.9M-13.94M-2.83M-2.75M-2.4M
Net Income -679k-3.54M-86.43M-2.93M-13.34M-2.83M-2.76M-2.4M
Preferred Dividends 00-7.92M-32k0000
Basic Earnings Per Share (EPS) 00000000
EBIT -985k-4.59M-17.05M-2.9M-1.78M-2.83M-2.75M-2.27M
EBITDA -985k-4.59M-5.15M-2.9M-1.78M-2.82M-2.75M-2.27M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -235k-820k-26.32M
Pre Tax Income -241k-820k-107.75M
Net Income -241k-75k-106.25M
Preferred Dividends 00-7.95M
Basic Earnings Per Share (EPS) -0.097-0.004-1.984
EBIT -235k-820k-26.32M
EBITDA -235k-819k-14.41M